Financial performance disclaimer for NLV and Sprout FundsTechnical Valuation Methodology for Private Equity Fund Metrics
Case Filekaggle-ho-024109House OversightCambridge Associates Healthcare VC Fund Methodology Document
Unknown1p4 persons
Case File
kaggle-ho-024109House OversightCambridge Associates Healthcare VC Fund Methodology Document
Cambridge Associates Healthcare VC Fund Methodology Document The passage contains only technical financial methodology and performance metrics for a venture capital fund, with no mention of individuals, transactions, or controversial actions. It offers no actionable investigative leads. Key insights: Describes IRR and multiple calculations for Sprout Funds.; Explains net vs. gross return adjustments.; Provides definitions of DPI and capital contribution calculations.
Date
Unknown
Source
House Oversight
Reference
kaggle-ho-024109
Pages
1
Persons
4
Integrity
No Hash Available
Loading document viewer...
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, ad-free, and independent.
Support This ProjectSupported by 1,550+ people worldwide
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.